UroGen raises $69M in follow-on

Cancer and genitourinary company UroGen Pharma Ltd. (NASDAQ:URGN) raised $69 million through the sale of 1.7 million shares at $41 in a follow-on underwritten by Jefferies, Cowen, Oppenheimer, Ladenb...